ACHL Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 16:00):

Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors...

Stats
Today's Volume	162 317
Average Volume	541 153
Market Cap	38.21M
EPS	$0 ( 2024-05-08 )
Next earnings date	( $-0.410 ) 2024-08-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.580
ATR14	$0.00800 (0.86%)

Volume Correlation

Long: 0.03 (neutral)

Short: -0.85 (strong negative)

Signal:(47.328) Neutral

Achilles Therapeutics plc Correlation

10 Most Positive Correlations
CRSP	0.844
SGMO	0.843
GRPN	0.833
NUVL	0.821
ANGI	0.818
FONR	0.806

10 Most Negative Correlations
RGLD	-0.876

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Achilles Therapeutics plc Correlation - Currency/Commodity

-0.25
( neutral )

-0.24
( neutral )

0.00
( neutral )

-0.11
( neutral )

Achilles Therapeutics plc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-4.73M (0.00 %)
EPS:	$-1.750

FY	2023
Revenue:	$0
Gross Profit:	$-4.73M (0.00 %)
EPS:	$-1.750

FY	2022
Revenue:	$0
Gross Profit:	$-3.69M (0.00 %)
EPS:	$-1.820

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-3.36

Financial Reports:

No articles found.

Achilles Therapeutics plc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Achilles Therapeutics plc

Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. The company was founded in 2016 and is headquartered in London, the United Kingdom.